Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R. Mato, Colleen Dorsey, Lindsey E. Roeker et al.|Clinical Cancer Research|2020Cited by 115
Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classificationRobert P. Hasserjian, Sa A. Wang, Armen Kasyan et al.|Blood|2009Cited by 108